## ROL: Rollins, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -5.1% below STRENGTH zone (4.0-10.0%); PEG 3.95 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($55.61)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. (ROL) Movement as an Input in Quant Signal Sets**
- Source: Stock Traders Daily | 20251207T092400 | Bullish | Relevance: 99%
- Rollins Inc. (NYSE: ROL) exhibits neutral near-term sentiment despite mid and long-term strength, with an identified mid-channel oscillation pattern. The AI analysis presents a 17.6:1 risk-reward setup targeting a 5.0% gain. Three distinct trading strategies are offered for varying risk profiles, alongside multi-timeframe signal analysis and real-time AI-generated signals for informed trading decisions.

**2. Subdued Growth No Barrier To Rollins, Inc.'s (NYSE:ROL) Price**
- Source: 富途牛牛 | 20251208T111527 | Neutral | Relevance: 99%
-  Rollins, Inc. (NYSE:ROL) trades at a high price-to-earnings (P/E) ratio of 57.3x, significantly above the market average of 18x, despite its subdued earnings growth. The company's recent EPS growth of 9.8% and anticipated 12% annual growth for the next three years are in line with the market. However, investors appear more bullish than analysts, leading to the elevated share price.

**3. Rollins Inc. stock underperforms Tuesday when compared to competitors**
- Source: MarketWatch | 20251209T163000 | Neutral | Relevance: 98%
-  Rollins Inc. (ROL) stock fell 4.18% to $58.01 on Tuesday, experiencing its second consecutive day of losses. This occurred during a general market downturn, with the S&P 500 Index and Dow Jones Industrial Average also seeing declines. The stock's performance underperformed compared to its competitors and broader market indices.

**4. Rollins Inc. stock underperforms Tuesday when compared to competitors**
- Source: MarketWatch | 20251209T163000 | Neutral | Relevance: 97%
- Rollins Inc. (ROL) stock fell 4.18% to $58.01 on Tuesday, underperforming the broader market downturn where the S&P 500 Index and Dow Jones Industrial Average also declined. This marked the second consecutive day of losses for the company's shares.

**5. Geron stock rating reiterated as Neutral by H.C. Wainwright**
- Source: Investing.com | 20251209T130947 | Neutral | Relevance: 53%
-  H.C. Wainwright reiterated its Neutral rating on Geron Corporation (NASDAQ:GERN) after the company's presentations at the ASH 2025 conference, where Geron provided incremental updates on its imetelstat clinical trials. Despite a significant year-to-date decline, Geron's stock showed a 3.25% gain over the past week and appears undervalued, according to InvestingPro. The company, which maintains strong liquidity, is not yet profitable, and recently reported a revenue shortfall for Q3 2025.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Barclays | $72 | $60 | +20% |
| 2025-11-12 | Bernstein | $70 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Barclays | up | Overweight |
| 2025-11-12 | Bernstein | init | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($3295.94M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 7.6% (+4.2%)
- Blackrock Inc.: 6.0% (+1.2%)
- State Street Corpora: 2.5% (+1.4%)
- Kayne Anderson Rudni: 2.0% (-2.8%)
- Geode Capital Manage: 2.0% (+1.7%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-5.0% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $3296M sold (6 transactions in 90 days).
3. Valuation stretched: PEG 3.9x requires aggressive growth execution.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.95 signals overvaluation risk, limited margin of safety. Forward P/E 45.3x stretched relative to 12% growth. Quality metrics strong (ROE 36%, ROA 15%). Analyst sentiment positive (1 raises, avg +20%). Insider selling cluster ($3295.9M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.9B |
| Beta | 0.79 |
| 52W Range | $45.34 - $61.84 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.95 |
| Forward P/E | 45.3 |
| Current P/E | 50.8 |
| YoY Growth | 12.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -0.1% to -5.1% (-5.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.1pp (needs >4.0% for momentum thesis). Underperforming sector by 4.2pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.03x) but short-term weakness (below SMA20). RSI neutral at 42.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.08% (CS: 17) | Weak |
| RSI_14 | 41.7 | Neutral |
| MACD Histogram | -0.22 | Bearish |
| vs SMA20 | 0.970x | Below |
| vs SMA50 | 0.995x | Below |
| vs SMA200 | 1.029x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $58.01
- **Stop Loss:** $55.61 (4.1% risk)
- **Target:** $60.41 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 208
- **Position Value:** $12,066.08
- **Portfolio %:** 12.07%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-18 (Est: $0.27)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.33 | $0.35 | +6.3% |
| 2025Q2 | $0.30 | $0.30 | -0.7% |
| 2025Q1 | $0.22 | $0.22 | +1.3% |
| 2024Q4 | $0.23 | $0.23 | -0.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*